Related Experiment Video
Updated: Aug 15, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Inhibitors of polyamine biosynthesis decrease the expression of the metalloproteases meprin alpha and MMP-7 in
Gail L Matters1, Andrea Manni, Judith S Bond
1Department of Biochemistry and Molecular Biology, The Pennsylvania State University College of Medicine, H171, Hershey, PA 17033-0850, USA.
Abstract:
Inhibition of ornithine decarboxylase (ODC), a key enzyme in polyamine biosynthesis, by the irreversible inhibitor alpha-difluoromethylornithine (DFMO) has been shown to decrease the invasiveness of metastatic human breast cancer cell lines. However, the mechanism by which DFMO acts to reduce invasiveness is unclear. Using the human breast cancer cell line MDA-MB-435, the effect of DFMO on metalloprotease gene expression was investigated. DFMO treatment decreases the expression of the metalloprotease meprin alpha, while concurrent treatment with DFMO and the polyamine putrescine partially restored meprin alpha expression levels. Expression of MMP-7 mRNA was reduced by DFMO, while MMPs-1, -2, -3, -14, and meprin beta were unaffected. Treatment of cells with a second inhibitor of polyamine biosynthesis, the S-adenosylmethionine decarboxylase (SAMDC) inhibitor SAM486A, also resulted in a dosage dependent decrease in meprin alpha and MMP-7 mRNA. In addition, DFMO treatment decreased meprin alpha at the protein level by 2 days of treatment, and MMP-7 protein levels at 4 and 6 days. Previous studies have shown that DFMO treatment increases ERK phosphorylation and signaling through the MAP kinase pathway. The decrease in meprin alpha expression was reversed with the MEK inhibitor PD98059, demonstrating that MAP kinase signaling mediates the effect of DFMO and SAM486A. MDA-MB-435 cells treated with the meprin alpha inhibitor actinonin (5 nM) were less invasive in vitro, indicating that meprin alpha is mechanistically involved in invasion. The decrease in meprin alpha expression in DFMO and SAM486A-treated cells indicates a means by which these compounds can decrease the invasiveness of metastatic breast cancer cells.
Insights
Alpha-difluoromethylornithine (DFMO) reduces breast cancer cell invasiveness by decreasing metalloprotease meprin alpha expression via MAP kinase signaling. This provides a mechanism for DFMO
Area of Science:
- Oncology
- Biochemistry
- Molecular Biology
Background:
- Metastatic breast cancer cell invasiveness is a critical factor in disease progression.
- Ornithine decarboxylase (ODC) is a key enzyme in polyamine biosynthesis, and its inhibition by alpha-difluoromethylornithine (DFMO) has been linked to reduced invasiveness.
- The precise mechanism by which DFMO reduces cancer cell invasiveness remains unclear.
Purpose of the Study:
- To investigate the effect of DFMO on metalloprotease gene expression in metastatic human breast cancer cells.
- To elucidate the signaling pathways involved in DFMO's mechanism of action.
- To determine the role of meprin alpha in breast cancer cell invasion.
Main Methods:
- Treatment of MDA-MB-435 breast cancer cells with DFMO and other polyamine biosynthesis inhibitors (SAM486A).
- Analysis of metalloprotease gene and protein expression (meprin alpha, MMP-7).
- Investigation of the role of the MAP kinase pathway using MEK inhibitor PD98059 and assessment of invasiveness with meprin alpha inhibitor actinonin.
Main Results:
- DFMO treatment decreased meprin alpha and MMP-7 mRNA and protein expression.
- Concurrent treatment with putrescine partially restored meprin alpha expression.
- MAP kinase signaling pathway activation by DFMO was demonstrated, and its inhibition reversed the decrease in meprin alpha expression.
- Inhibition of meprin alpha reduced breast cancer cell invasiveness in vitro.
Conclusions:
- DFMO and SAM486A decrease breast cancer cell invasiveness, at least in part, by reducing meprin alpha expression.
- The observed effect is mediated through the MAP kinase signaling pathway.
- Meprin alpha plays a mechanistic role in the invasiveness of metastatic breast cancer cells.
Related Concept Videos
Abnormal Proliferation
Role of Matrix Metalloproteases in Degradation of ECM
A...
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...